Fundraising Fox
/Companies
Sign in

Etiome

Founded 2021 · 26 employees on LinkedIn · 1 known investors

Find your way into Etiome

Sign up to see every warm intro you have to Etiome

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Etiome team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Etiome develops stage-specific medicines by applying single-cell omics and artificial intelligence to map disease progression and identify disease-modifying targets at early biological inflection points for preemptive intervention. Founded in 2021 out of Flagship Pioneering's Preemptive Health and Medicine initiative, the biotech company focuses on treating or reversing disease before it advances to later stages.

AI & Machine LearningBiotechLongevity

Founders & leadership

KVKatharine von Herrmann
Katharine von HerrmannCo-founder
AKAvak Kahvejian
Avak KahvejianFounding Team; Founding CEOAvak Kahvejian is founding CEO of Etiome, a biotech company developing stage-specific medicines using single-cell omics and AI to identify disease-modifying targets. He previously worked at Flagship Pioneering, where he conceived and launched platform companies focused on novel biological mechanisms and biotechnologies.
NANoubar Afeyan
Noubar AfeyanFounding TeamInvestor at Flagship Pioneering
SLScott Lipnick
Scott LipnickFounding TeamScott Lipnick is a member of the founding team at Etiome, a biotech company developing stage-specific medicines using single-cell omics and AI to identify disease-modifying targets for early intervention. He previously worked at Flagship Pioneering, where he collaborated on the Preemptive Health and Medicine initiative and co-founded multiple companies focused on preemptive health approaches.
TSTorben Straight Nissen
Torben Straight NissenFounding Team; Board DirectorExecutive Officer, Director at Rubius Therapeutics
YEYann Echelard
Yann EchelardFounding Team; Chief Operating Officer
ARAdrian Rawcliffe
Adrian RawcliffeCEO-Partner & Chief Executive Officer
JL
Jean LachowiczChief Scientific Officer
SE
Sandi EngleHead of Biology
ASArtem Sokolov
Artem SokolovHead of Computational BiologyArtem Sokolov is Head of Computational Biology at Etiome, a biotech company developing stage-specific medicines through single-cell omics and artificial intelligence to identify early disease intervention targets. His research background spans computational biology and disease modeling, as evidenced by his scholarly publications and software development work.

Investors · 1

Founder mafia

4 people who came through Etiome went on to found or lead other companies.

Noubar AfeyanFounding TeamFounded ProFound Therapeutics +15Avak KahvejianFounding Team; Founding CEOFounded ProFound Therapeutics +5Adrian RawcliffeCEO-Partner & Chief Executive OfficerFounded AdaptimmuneTorben Straight NissenFounding Team; Board DirectorFounded Repertoire Immune Medicines

In the news

Etiome Steps Out of Stealth With $50M to Address Disease At The 'Silent Stage' - BioSpacebiospace.com · Apr 2025

Frequently asked questions

What does Etiome do?
Etiome develops stage-specific medicines by applying single-cell omics and artificial intelligence to map disease progression and identify disease-modifying targets at early biological inflection points for preemptive intervention. Founded in 2021 out of Flagship Pioneering's Preemptive Health and Medicine initiative, the biotech company focuses on treating or reversing disease before it advances to later stages.
Who founded Etiome?
Etiome was founded by Katharine von Herrmann, Avak Kahvejian, Noubar Afeyan, Scott Lipnick, Torben Straight Nissen, Yann Echelard in 2021.
Who are Etiome's investors?
Etiome's investors include Flagship Pioneering.